Trials / Completed
CompletedNCT01962077
Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.
Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 2 Years – 10 Years
- Healthy volunteers
- Accepted
Summary
assess the effect of MedCem MTA as a pulp medicament following pulpotomy in human primary molars with carious pulp exposure in comparison to Formocresol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MedCem MTA pulpotomies in primary teeth. |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2013-10-14
- Last updated
- 2021-07-06
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01962077. Inclusion in this directory is not an endorsement.